戻る Agenda
S16 : How will Post-Marketing Safety Measures Change with the Revision of the Pharmaceuticals and Medical Devices Act?
Session Chair(s)
Mamoru Narukawa, PHD, RPH
Professor, Kitasato University, Japan
Speaker(s)
Takashi YASUKAWA
Director, Pharmaceutical Safety Division, Pharmaceutical Safety Bureau, Ministry of Health, Labour and Welfare (MHLW), Japan
Makoto Miyazaki, PHD
Chairperson, Pharmacovigilance Expert Committee, Drug Evaluation Committee, JPMA, Japan
Susumu Wakabayashi
Department of Pharmacy, Kyorin University Hospital, Japan